Drug Type AAV based gene therapy |
Synonyms SERPING1 gene therapy (Spark Therapeutics) |
Target |
Action stimulants |
Mechanism C1-INH stimulants(serpin family G member 1 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hereditary Angioedema | Preclinical | United States | - |





